Literature DB >> 29323989

Rapid response: a multiprofessional approach to hospital at home.

Sara Dowell1, George Moss1, Katy Odedra1.   

Abstract

The provision of 'hospital at home' is not new to the 21st century but pressure from the reduction in the number of hospital beds, population growth, an ageing population and subsequent extended time living with long-term conditions means such services are increasingly necessary. However, research by the authors found services that already exist do not operate 24 hours a day or provide a single multiprofessional approach. Gloucestershire's rapid response (RR) service provides specialist, coordinated, comprehensive and supportive assessment and treatment 24 hours a day in the patient's own home. Data were collected over a 5-month period detailing the number of patients admitted to the service and its impact on hospital admission avoidance and patient outcome. The cost savings and reduction in length of hospital stay is considerable (to almost a quarter of the cost and number of bed days of an acute hospital admission). The position of the hospital as the main provider of urgent/acute care is shifting. The RR service demonstrates its position as a provider of an innovative service that breaks down the boundaries between acute, primary and social care.

Entities:  

Keywords:  Admission avoidance; Hospital at home; Multiprofessional working; Rapid response

Mesh:

Year:  2018        PMID: 29323989     DOI: 10.12968/bjon.2018.27.1.24

Source DB:  PubMed          Journal:  Br J Nurs        ISSN: 0966-0461


  1 in total

1.  Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility.

Authors:  Ignacio Gómez-Centurión; Gillen Oarbeascoa; María Carmen García; María Carmen López Fresneña; María Josefa Martínez Carreño; Vicente Escudero Vilaplana; Eva González-Haba; Rebeca Bailén; Nieves Dorado; Luis Miguel Juárez; Gabriela Rodríguez Macías; Patricia Font López; Cristina Encinas; Mariana Bastos-Oreiro; Javier Anguita; María Sanjurjo; José Luis Díez-Martin; Mi Kwon
Journal:  Int J Hematol       Date:  2021-09-22       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.